Keyphrases
Prostate Cancer
100%
ACK1
96%
Castration-resistant Prostate Cancer
73%
Phosphorylation
71%
TNK2
69%
Androgen Receptor
69%
Clear Cell Renal Cell Carcinoma (ccRCC)
61%
Essential Pathway
61%
Transcriptomic Characterization
61%
Epigenetics
61%
Progression Markers
61%
Tyrosine Kinase
49%
Tumor Cells
47%
Acetylation
42%
Cytomorphology
37%
Immunohistochemistry
36%
Therapeutic Vulnerabilities
33%
Conflict of Interest
30%
Plasma Cell Neoplasm
30%
Cytological Samples
30%
BerEP4
30%
Androgen Production
30%
Histone H2A
30%
Potential Conflict
30%
MOC31
30%
Urinary Bladder Mass
30%
PARP Inhibitor (PARPi)
30%
Insurance Medicine
30%
Transbronchial Aspiration
30%
Advanced Prostate Cancer
30%
Clinical Proteomic Tumor Analysis Consortium
30%
National Cancer Institute
30%
Declare
30%
Competing Interests
30%
Specific Antibodies
30%
Bladder Mass
30%
Epithelial Cell Adhesion Molecule (EpCAM)
30%
Vulnerability
30%
Cdc42
30%
Follicular Dendritic Cell Sarcoma
30%
Urinary Bladder
30%
Lung Cancer
30%
HOXB13
30%
ATP Synthase
30%
Ultrasound-guided
30%
Molecular Markers
30%
Therapeutic Targeting
30%
Endobronchial Ultrasound
30%
Mass-like Lesion
30%
Diagnostic pitfalls
30%
Medicine and Dentistry
Diagnosis
66%
Immunohistochemistry
51%
Neoplasm
45%
Malignant Neoplasm
41%
Cytotechnology
41%
Prostate Cancer
35%
Tumor Cell
31%
Proteomics
30%
Lung Cancer
30%
Follicular Dendritic Cell Sarcoma
30%
PARP1
30%
Homologous Recombination
30%
Molecular Marker
30%
Clear Cell Renal Cell Carcinoma
30%
Epithelial Cell Adhesion Molecule
30%
Transbronchial Aspiration
30%
Endobronchial Ultrasonography
30%
Plasmacytoma
30%
Bladder
30%
Recombination Repair
30%
Transcriptomics
30%
Antibodies
30%
Homeostasis
30%
Histone H3
30%
Androgen Receptor
30%
Effusion
23%
Carcinoma
23%
Non Small Cell Lung Cancer
22%
PARP Inhibitor
20%
Hematopoietic System Malignancy
15%
Poly ADP Ribose Polymerase
15%
Epidermal Growth Factor Receptor
13%
Reactive Oxygen Species
13%
Anaplastic Lymphoma Kinase
13%
Programmed Death-Ligand 1
13%
Cancer
13%
Positron Emission Tomography-Computed Tomography
10%
Germinal Center
10%
Fine-Needle Aspiration
10%
Cytodiagnosis
10%
Immunophenotyping
10%
Liquid-Based Cytology
10%
Follicular Dendritic Cells
10%
Diagnostic Error
10%
Lymphocyte
10%
Adenocarcinoma
8%
Adverse Event
8%
Transitional Cell Carcinoma
8%
Noonan Syndrome with Multiple Lentigines
8%
Mesothelial Cell
7%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
73%
Epigenetics
61%
Kinase
47%
Phosphotransferase
47%
Acetylation
41%
Tyrosine Kinase
39%
Receptor Tyrosine Kinase
39%
Cancer Cell
33%
Enhancer Region
33%
Transcriptomics
30%
ATP Synthase
30%
Histone H2A
30%
Ferroxidase
30%
Ceruloplasmin
30%
Androgen Synthesis
30%
Troponin I
30%
CDC42
30%
Alpha Chain
30%
HOXB13
30%
Immune Checkpoints
30%
C-Terminus
30%
Enzyme
30%
Histone H3
30%
Homeostasis
30%
Enzalutamide
19%
Tumor Progression
19%
Mitophagy
18%
Non-Receptor Tyrosine Kinase
18%
Tyrosine
15%
Mitochondrion
12%
Troponin
11%
Population
11%
T Cell
11%
Proteogenomics
10%
Carcinogenesis
10%
Mesenchymal-Epithelial Transition
10%
PBRM1
10%
BAP1
10%
Volume
10%
Tamsulosin
10%
Receptor Antagonist
6%
Microtubule-Associated Protein
6%
Macromolecule
6%
Light Chain
6%
Autophagy
6%
Cell Growth
6%
Transgenic Mouse
6%
PINK1
6%
Ubiquitin
6%
Nomenclature
6%